Rennova Health (RNVA) Stock Price, News & Analysis

Company Overview

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0001
• Volume: 500,000 shs
• Average Volume: 1.64 million shs
• Market Capitalization: $4.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RNVA Stock Analysis - Frequently Asked Questions

How have RNVA shares performed this year?

Rennova Health's stock was trading at $0.0001 at the beginning of the year. Since then, RNVA stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here.

How were Rennova Health's earnings last quarter?

Rennova Health, Inc. (OTCMKTS:RNVA) released its quarterly earnings data on Tuesday, August, 14th. The company reported $2,500,000,000.00 earnings per share for the quarter. The business had revenue of $3.29 million for the quarter.

When did Rennova Health's stock split?

Rennova Health shares reverse split on Wednesday, March 16th 2022. The 1-10000 reverse split was announced on Wednesday, March 16th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

How do I buy shares of Rennova Health?

Shares of RNVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Rennova Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), LadRx (CYTR), NightHawk Biosciences (NHWK), Precipio (PRPO), 22nd Century Group (XXII) and Biopharmx (BPMX).

Company Calendar

• Last Earnings: 8/14/2018
• Today: 1/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: General medical & surgical hospitals
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:RNVA
• Previous Symbol: NASDAQ:RNVA
• CUSIP: N/A
• CIK: 931059
• Web: www.rennovahealth.com
• Phone: 561-855-1626
• Fax: 415-248-5351
• Employees: 60
• Year Founded: 1995

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $13.04 million
• Price / Sales: 0.31
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 40,551,320,000
• Free Float: 18,037,227,000
• Market Cap: $4.06 million
• Optionable: Not Optionable
• Beta: 14.66